Literature DB >> 27074234

Infections and systemic lupus erythematosus.

Thelma Larocca Skare1, Jéssica Scherer Dagostini1, Patricia Imai Zanardi1, Renato Mitsunori Nisihara2.   

Abstract

OBJECTIVE: To determine the incidence of infections in a population of systemic lupus erythematosus individuals and the characteristics of infections regarding original site, as well as to study the possible associations between infections and treatment.
METHODS: An analytical retrospective study using data from medical charts of systemic lupus erythematosus patients from a single university hospital. A total of 144 patients followed up for five years were included. Data collected comprised age of patients and age at onset of lupus, sex and ethnicity, disease duration before the study period, medications, cumulative dose of prednisone, occurrence of infections and their original site.
RESULTS: The most frequent infections were urinary tract infections (correlated to use of prednisone - p<0.0001 and cyclophosphamide - p=0.045), upper airways infections (correlated to use of prednisone - p=0.0004, mycophenolate mofetil - p=0.0005, and cyclosporine - p=0.025), and pneumonia (associated to prednisone - p=0.017).
CONCLUSION: Prednisone was the drug more often associated with presence of infections, pointing to the need for a more judicious management of this drug.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27074234      PMCID: PMC4872917          DOI: 10.1590/S1679-45082016AO3490

Source DB:  PubMed          Journal:  Einstein (Sao Paulo)        ISSN: 1679-4508


  25 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

2.  The bimodal mortality pattern of systemic lupus erythematosus.

Authors:  M B Urowitz; A A Bookman; B E Koehler; D A Gordon; H A Smythe; M A Ogryzlo
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

3.  The nature and outcome of infection in systemic lupus erythematosus.

Authors:  D D Gladman; F Hussain; D Ibañez; M B Urowitz
Journal:  Lupus       Date:  2002       Impact factor: 2.911

Review 4.  Genetics and novel aspects of therapies in systemic lupus erythematosus.

Authors:  Manfred Relle; Julia Weinmann-Menke; Eva Scorletti; Lorenzo Cavagna; Andreas Schwarting
Journal:  Autoimmun Rev       Date:  2015-07-09       Impact factor: 9.754

5.  Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients.

Authors:  X Bosch; A Guilabert; L Pallarés; R Cerveral; M Ramos-Casals; A Bové; M Ingelmo; J Font
Journal:  Lupus       Date:  2006       Impact factor: 2.911

6.  Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus.

Authors:  Su Jin Jeong; Heekyung Choi; Han Sung Lee; Sang Hoon Han; Bum Sik Chin; Ji-Hyeon Baek; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Scand J Infect Dis       Date:  2009

7.  Infection in systemic lupus erythematosus.

Authors:  M Khalifa; N Kaabia; F Bahri; E Ben Jazia; E Bouajina; A Omezzine Letaief
Journal:  Med Mal Infect       Date:  2007-09-17       Impact factor: 2.152

Review 8.  Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies.

Authors:  A Danza; G Ruiz-Irastorza
Journal:  Lupus       Date:  2013-10       Impact factor: 2.911

Review 9.  Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus.

Authors:  Raquel Cuchacovich; Abraham Gedalia
Journal:  Rheum Dis Clin North Am       Date:  2009-02       Impact factor: 2.670

10.  Predictors of major infections in systemic lupus erythematosus.

Authors:  Guillermo Ruiz-Irastorza; Nerea Olivares; Ioana Ruiz-Arruza; Agustin Martinez-Berriotxoa; Maria-Victoria Egurbide; Ciriaco Aguirre
Journal:  Arthritis Res Ther       Date:  2009-07-15       Impact factor: 5.156

View more
  1 in total

1.  Nocardia asteroides occipital abscess as a cause of lupus nephritis?

Authors:  Francis Essien; Graey Wolfley; Joshua Tate; Wayne Latack; Matthew Carroll
Journal:  Clin Case Rep       Date:  2022-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.